Steven R Francis, MD | |
61st Medical Squadron, 483 N. Aviation Blvd Bldg 210, El Segundo, CA 90245 | |
(702) 653-2764 | |
Not Available |
Full Name | Steven R Francis |
---|---|
Gender | Male |
Speciality | Preventive Medicine - Aerospace Medicine |
Location | 61st Medical Squadron, El Segundo, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417253345 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083A0100X | Preventive Medicine - Aerospace Medicine | ME125684 (Florida) | Primary |
Mailing Address | Practice Location Address |
---|---|
Steven R Francis, MD 4700 Las Vegas Blvd N, Nellis Afb, NV 89191-6600 Ph: (702) 653-2764 | Steven R Francis, MD 61st Medical Squadron, 483 N. Aviation Blvd Bldg 210, El Segundo, CA 90245 Ph: (702) 653-2764 |
News Archive
Tomophase Corporation, a leading developer of non-invasive optical coherence tomography (OCT) tissue imaging devices, announced today that it has received notification of the issuance of its seventh patent: Delivering Light via Optical Waveguide and Multi-view Optical Probe Head, U. S. Patent # 7,706,646.
Advocates caution that California's ambitious program for dual eligibles could be problematic, while Colorado's effort to move Medicaid patients into medical homes is showing savings.
In a new and unique study to determine if genes on the Y chromosome are involved in prostate cancer, researchers at Columbia University's Mailman School of Public Health in conjunction with Hebrew University of Jerusalem found that men who had only daughters had a higher risk of prostate cancer than men who had at least one son, thus signifying a possible defect on the father's Y chromosome.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostics systems and technology for HIV, hepatitis, tuberculosis, cholera and malaria detection, and other innovative technologies, in a new video today unveiled the world's first urine-based tuberculosis diagnostics tool.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that National Government Services has issued a positive coverage decision for Posterior Tibial Nerve Stimulation (PTNS) for the treatment of urinary urgency, urinary frequency and urge incontinence associated with overactive bladder (OAB). Coverage for the proprietary Urgent PC device was effective August 10, 2014.
› Verified 7 days ago
Dr. Anton Volpicelli, D.O. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 N Nash St, El Segundo, CA 90245 Phone: 310-640-9911 |